Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (VRCA)

CUSIP: 92511W207

Q1 2026 13F Holders as of 31 Mar 2026

Holder snapshot 6 signals
Share change
-534,754
SEC-reported price per share
$5.29
Number of holders
39
Value change
-$4,207,213
Number of buys
13
Number of sells
22
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
8,810,762

Security key

92511W207

Report period

Q1 2026

Institutions

39

Top holders

10

Ownership snapshot

Top reported holders of VRCA - Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Paul B. Manning
Disclosed value leader
PERCEPTIVE ADVISORS LLC
Comparable rows
15/15
Latest evidence
22 Jan 2026
3/4/5 13D/G 13F Lead comparable stake: 50% 13D/G row: Paul B. Manning Showing 1-6 of 15 holder rows.

Quick read

Paul B. Manning leads the comparable SEC ownership view at 50%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Paul B. Manning's linked filing trail.
Comparable ownership Top 5
Paul B. Manning 50%
Caligan Partners LP 10%
Affinity Asset Advisors, LLC 5.5%
ARMISTICE CAPITAL, LLC 5%
PERCEPTIVE ADVISORS LLC 1.6%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Paul B. Manning
3/4/5 13D/G
Director, 10%+ Owner
50%
from 13D/G
$32,171,572
31,591,877 shares
mixed-class rows
+$17,505,157 25 Nov 2025
Caligan Partners LP
13D/G 3/4/5 13F
Other* · Company
10%
$43,635,492
6,503,054 shares
$0 26 Dec 2025
Affinity Asset Advisors, LLC
13D/G 13F
Company
5.5%
$7,346,762
884,172 shares
$0 22 Jan 2026
ARMISTICE CAPITAL, LLC
13F 13D/G
Company
5%
from 13D/G
$9,298,267
1,118,925 shares
31 Dec 2025
PERCEPTIVE ADVISORS LLC
3/4/5 13D/G
10%+ Owner
1.6%
from 13D/G
$51,398,078
7,099,182 shares
27 Dec 2023
BKB Growth Investments, LLC
3/4/5
10%+ Owner
38%
$27,822,292
3,348,372 shares
25 Nov 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
39
Shares
4,777,869
Rows available
39
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2026 vs Q4 2025 Across Filers

Q4 2025 holders
49
Q1 2026 holders
39
Holder diff
-10
Investor Q4 2025 Shares Q1 2026 Shares Share Diff Share Chg % Q4 2025 value Q1 2026 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .